Last Updated: 01/10/2024
West African Network for TB, AIDS and Malaria (WANETAM III)
Objectives
The malaria program will explore the efficacy of malaria treatments and the effectiveness of mass drug interventions. Work package 2 of the network aims at increasing capacities for the evaluation of new interventions, treatments, and vaccines able to further reduce and interrupt malaria transmission
The specific objectives of this project are;
- Strategic project-based training to build research leadership
- Hands-on operational and clinical studies that inform clinical trial plans and prevention
- Resource & platform infrastructure development
- Surveillance to build evidence-based for clinical trial
- Diagnosis to support intervention
- Building on quality assurance and expanding laboratory accreditation
Medical Research Council (MRC) Unit The Gambia at the London School of Hygiene and Tropical Medicine, The Gambia
University of Sciences Techniques and Technologies of Bamako (USTTB), Mali
Health Action Research Group (GRAS), Burkina Faso
Institut Pasteur of Dakar (IPD), Senegal
Cheikh Anta Diop University (UCAD), Senegal
Nigerian Institute of Medical Research, Nigeria
Institute of Human Virology Nigeria (IHVN), Nigeria
University of Jos (UniJos), Nigeria
Institute of Research for Development (IRD), Benin
Research Center Borstel – Leibniz Lung Center (FZB), Germany
Heidelberg University Hospital, Germany
National Center for Scientific and Technological Research (CNRST) Burkina Faso, Burkina Faso
University of Ghana (UG), Ghana
University of Lomé (UL), Togo
University of Ibadan, Nigeria
NOVA University Lisbon (UNL), Portugal
WANETAM is a network of institutions in West Africa and Europe focused on building sustainable expertise for conducting clinical trials and research on poverty-related diseases. The third phase of the project will include training, resource development, and surveillance activities to strengthen capacity and collaboration.WANETAM-3 will build on the activities of the disease-defined work packages (WPs): TB, Malaria, HIV, Neglected Tropical Diseases, Emerging Infections response and preparedness and the inclusion of the cross-cutting trainings that strengthens capacity of individuals in specialised skills needed in clinical research and the capacity of supporting infrastructure. The WPs will consolidate the mission to achieve sustainable capacity and multi-institutional collaboration in clinical research through activities. Researcher leadership trainings are also proposed through grant writing and mentorship masterclass training workshops, pilot studies and work-visits. Scientists will be supported for grant applications to achieve sustainability. The generation of data will increase during WANETAM-3 from the TB multi-drug resistance surveillance and diagnostic work, the Malaria elimination cluster-randomised studies and HIV drug-resistance cohorts and therefore, calls for the establishment of WANETAM database management and sharing platform. This project will also strengthen ethics capacity. The network will respond to the need to strengthen research in COVID-19; work will be done on the impact of covid-19 on the disease entities and support the partner laboratories in diagnosis and sequencing of Covid-19 strains.
Capacity Building
Diagnostics
Drug-based Strategies
Health Systems & Op. Research
Leadership & Governance
Surveillance
Aug 2021 — May 2025
$4.88M
Related Resources
